• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症患者及其照料者的生活质量

Patient and caregiver quality of life in Huntington's disease.

作者信息

Ready Rebecca E, Mathews Melissa, Leserman Anne, Paulsen Jane S

机构信息

Department of Psychology, University of Massachusetts, Amherst, Massachusetts 01003, USA.

出版信息

Mov Disord. 2008 Apr 15;23(5):721-6. doi: 10.1002/mds.21920.

DOI:10.1002/mds.21920
PMID:18175350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3789516/
Abstract

Little is known about subjective perceptions of quality of life (QOL) in Huntington's disease (HD). The current study determined correlates of patient and caregiver QOL and assessed change over time. Participants were 22 patient-caregiver dyads, who rated QOL at baseline and 6 months later. Overall, patients' functional and cognitive impairment were significantly correlated with patient and caregiver QOL. Neuropsychiatric symptoms had differential impact on patient and caregiver QOL. Furthermore, when patients recalled their QOL about a previous time, their recall may have been negatively biased. Clinical implications of results are discussed. Future work is needed because subjective QOL is an important outcome measure in therapeutic trials.

摘要

关于亨廷顿舞蹈症(HD)患者生活质量(QOL)的主观认知,我们了解甚少。本研究确定了患者和照料者生活质量的相关因素,并评估了随时间的变化情况。研究参与者为22对患者-照料者组合,他们在基线时和6个月后对生活质量进行了评分。总体而言,患者的功能和认知障碍与患者及照料者的生活质量显著相关。神经精神症状对患者和照料者生活质量的影响存在差异。此外,当患者回忆其之前某段时间的生活质量时,他们的回忆可能存在负性偏差。本文讨论了研究结果的临床意义。鉴于主观生活质量是治疗试验中的一项重要结果指标,未来仍需开展相关工作。

相似文献

1
Patient and caregiver quality of life in Huntington's disease.亨廷顿舞蹈症患者及其照料者的生活质量
Mov Disord. 2008 Apr 15;23(5):721-6. doi: 10.1002/mds.21920.
2
Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?从患者、护理人员和医生的角度看亨廷顿病:同一枚硬币的三个面?
J Neural Transm (Vienna). 2012 Nov;119(11):1361-5. doi: 10.1007/s00702-012-0787-x. Epub 2012 Mar 8.
3
Assessment of Caregiver Burden in Huntington's Disease.亨廷顿舞蹈症患者照料者负担的评估
J Huntingtons Dis. 2019;8(1):111-114. doi: 10.3233/JHD-180326.
4
Brain, cognitive, and physical disability correlates of decreased quality of life in patients with Huntington's disease.亨廷顿病患者生活质量下降与大脑、认知和身体残疾的相关性。
Qual Life Res. 2023 Jan;32(1):171-182. doi: 10.1007/s11136-022-03220-0. Epub 2022 Aug 17.
5
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.亨廷顿病的生活质量:评估患者健康相关生活质量和护理人员生活质量的测量方法的批判与建议。
Mov Disord. 2018 May;33(5):742-749. doi: 10.1002/mds.27317. Epub 2018 Mar 23.
6
Assessing Alzheimer's disease patients' quality of life: Discrepancies between patient and caregiver perspectives.评估阿尔茨海默病患者的生活质量:患者和照护者观点的差异。
Alzheimers Dement. 2016 Apr;12(4):427-37. doi: 10.1016/j.jalz.2015.09.003. Epub 2015 Oct 24.
7
Quality of life in couples living with Huntington's disease: the role of patients' and partners' illness perceptions.亨廷顿舞蹈症患者夫妇的生活质量:患者及伴侣疾病认知的作用
Qual Life Res. 2007 Jun;16(5):793-801. doi: 10.1007/s11136-007-9194-4. Epub 2007 Mar 21.
8
Living with Huntington's disease: illness perceptions, coping mechanisms, and spouses' quality of life.与亨廷顿舞蹈症相伴:疾病认知、应对机制及配偶的生活质量。
Int J Behav Med. 2002;9(1):37-52. doi: 10.1207/s15327558ijbm0901_03.
9
Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.亨廷顿舞蹈症患者及护理者群体调查揭示最具影响的症状和治疗需求
J Huntingtons Dis. 2016 Dec 15;5(4):395-403. doi: 10.3233/JHD-160228.
10
Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.阿尔茨海默病患者生活质量的家庭照料者评分预测因素:来自加拿大阿尔茨海默病生活质量研究的横断面结果。
Am J Geriatr Psychiatry. 2011 Oct;19(10):891-901. doi: 10.1097/JGP.0b013e3182006a7f.

引用本文的文献

1
Emotional speech markers of psychiatric disturbance in Huntington's disease.亨廷顿舞蹈症精神障碍的情感言语标记
Front Psychiatry. 2025 Aug 12;16:1633492. doi: 10.3389/fpsyt.2025.1633492. eCollection 2025.
2
Restoring endogenous Dlg4/PSD95 expression by an artificial transcription factor ameliorates cognitive and motor learning deficits in the R6/2 mouse model of Huntington's disease.通过人工转录因子恢复内源性Dlg4/PSD95表达可改善亨廷顿舞蹈病R6/2小鼠模型的认知和运动学习缺陷。
Clin Epigenetics. 2025 Jun 12;17(1):100. doi: 10.1186/s13148-025-01903-2.
3
Acceptance and commitment therapy with Huntington's disease: A narrative review and case report of a caregiver-assisted intervention.亨廷顿舞蹈病的接纳与承诺疗法:一项护理者辅助干预的叙述性综述及病例报告
J Huntingtons Dis. 2025 Feb;14(1):3-15. doi: 10.1177/18796397251315162. Epub 2025 Jan 28.
4
Validation of the Korean Version of the Huntington's Disease Quality of Life Battery for Carers.韩国版亨廷顿舞蹈病患者照料者生活质量量表的验证
J Mov Disord. 2025 Apr;18(2):160-164. doi: 10.14802/jmd.24217. Epub 2024 Dec 30.
5
Shifting focus from ideality to reality: a qualitative study on how quality of life is defined by premanifest and manifest Huntington's disease gene expansion carriers.从理想主义到现实主义的转变:一项定性研究,探讨无症状和有症状亨廷顿病基因突变携带者如何定义生活质量。
Orphanet J Rare Dis. 2024 Nov 29;19(1):444. doi: 10.1186/s13023-024-03461-x.
6
Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments: A Decision-Modeling Analysis.亨廷顿舞蹈症的长期健康结局及未来疾病修饰治疗的影响:一项决策模型分析
Neurol Clin Pract. 2024 Oct;14(5):e200340. doi: 10.1212/CPJ.0000000000200340. Epub 2024 Aug 15.
7
Evidence-Based Review on Symptomatic Management of Huntington's Disease.亨廷顿舞蹈症症状管理的循证综述
J Mov Disord. 2024 Oct;17(4):369-386. doi: 10.14802/jmd.24140. Epub 2024 Aug 9.
8
Development of the Huntington Support App (HD-eHelp study): a human-centered and co-design approach.亨廷顿支持应用程序的开发(HD-eHelp研究):一种以人为本的协同设计方法。
Front Neurol. 2024 Jul 1;15:1399126. doi: 10.3389/fneur.2024.1399126. eCollection 2024.
9
The Dosing of Mobile-Based Just-in-Time Adaptive Self-Management Prompts for Caregivers: Preliminary Findings From a Pilot Microrandomized Study.针对护理人员的基于移动设备的即时自适应自我管理提示的剂量:一项微型随机试验的初步结果
JMIR Form Res. 2023 Sep 14;7:e43099. doi: 10.2196/43099.
10
The reliability and validity of the TBI-CareQOL system in four diverse caregiver groups.TBI-CareQOL 系统在四个不同照护者群体中的信度和效度。
J Patient Rep Outcomes. 2023 Jun 26;7(1):57. doi: 10.1186/s41687-023-00602-x.

本文引用的文献

1
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Patient-reported outcomes in clinical trials for Alzheimer's disease.对《健康经济学与阿尔茨海默病治疗的价值》的评论。阿尔茨海默病临床试验中的患者报告结局。
Alzheimers Dement. 2007 Jul;3(3):172-6. doi: 10.1016/j.jalz.2007.04.385.
2
The Huntington's disease quality of life battery for carers: reliability and validity.亨廷顿病照顾者生活质量量表:信度与效度
Clin Genet. 2007 May;71(5):434-45. doi: 10.1111/j.1399-0004.2007.00784.x.
3
Quality of life in couples living with Huntington's disease: the role of patients' and partners' illness perceptions.亨廷顿舞蹈症患者夫妇的生活质量:患者及伴侣疾病认知的作用
Qual Life Res. 2007 Jun;16(5):793-801. doi: 10.1007/s11136-007-9194-4. Epub 2007 Mar 21.
4
The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS.肌萎缩侧索硬化症生活质量量表:在评估肌萎缩侧索硬化症患者生活质量时平衡身体和非身体因素
Neurology. 2006 Nov 14;67(9):1659-64. doi: 10.1212/01.wnl.0000242887.79115.19.
5
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.行业指南:患者报告的结局指标:用于医疗产品开发以支持标签声明:指南草案
Health Qual Life Outcomes. 2006 Oct 11;4:79. doi: 10.1186/1477-7525-4-79.
6
A review of the health-related quality of life and economic impact of Parkinson's disease.帕金森病的健康相关生活质量及经济影响综述。
Drugs Aging. 2006;23(9):693-721. doi: 10.2165/00002512-200623090-00001.
7
A four-year prospective study of cognitive functioning in Huntington's disease.一项关于亨廷顿舞蹈症认知功能的四年前瞻性研究。
J Int Neuropsychol Soc. 2006 Jul;12(4):445-54.
8
Probability of obsessive and compulsive symptoms in Huntington's disease.亨廷顿舞蹈症中强迫症状的概率。
Biol Psychiatry. 2007 Feb 1;61(3):415-8. doi: 10.1016/j.biopsych.2006.04.034. Epub 2006 Jul 12.
9
Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life.普拉克索与左旋多巴治疗早期帕金森病患者:对一般生活质量和疾病特异性生活质量的影响。
Value Health. 2006 Jan-Feb;9(1):28-38. doi: 10.1111/j.1524-4733.2006.00078.x.
10
A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.多奈哌齐、卡巴拉汀和加兰他敏对阿尔茨海默病认知、生活质量及不良事件临床疗效的系统评价。
Int J Geriatr Psychiatry. 2006 Jan;21(1):17-28. doi: 10.1002/gps.1402.